Basilea Pharmaceutica’s CHF 45.75 Million Shares Offering

Baker McKenzie advised Basilea Pharmaceutica Ltd. on all legal aspects of this PIPE transaction. Homburger advised the managers.Basilea Pharmaceutica Ltd. successfully completed a capital increase from authorized…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here